Azetidine compounds as orexin receptor antagonists
申请人:Actelion Pharmaceuticals Ltd.
公开号:US07994336B2
公开(公告)日:2011-08-09
The invention relates to novel azetidine compounds of formula (I), wherein R1, R2, and X are as described in the description and their use as orexin receptor antagonists.